Idorsia
Julien Frey is an experienced financial professional currently serving as Associate Director of Financial Planning & Analysis at Idorsia Pharmaceuticals Ltd since March 2018. Frey's expertise encompasses budgeting, forecasting, and consolidation of operating expenses, alongside supporting external reporting and providing internal management reports. Previous roles include Treasurer at Eco-Gestion Conseil and various finance-related internships at POULAILLON and Actelion, where Julien gained skills in accounting, financial analysis, and data management. Academic credentials include a Master's degree in Corporate Finance from Sciences Po Strasbourg and a Master's in Finance from the University of Strasbourg.
This person is not in any teams
This person is not in any offices
Idorsia
4 followers
Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.